The Record - for physicians and other health care providers to share with their office staffs Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

June 2015

Certificate of Medical Necessity requirements for home infusion therapy program

The home infusion therapy program requires a Certificate of Medical Necessity for each therapy type, with a dated physician signature within 90 days of the start-of-care date. Each CMN must meet the guideline requirements as stated in the HIT manual, with no exceptions.

A CMN lasts 120 days. When the therapy is ordered beyond the 120-day limit, the CMN must be renewed with all the required information and signed within 90 days of the renewal date.

The pharmacist may take a verbal order related to the drug therapy without a physician co-signature; however a CMN renewal must be signed by the ordering physician within 90 days of the renewal date. Claims can’t be billed until the physician returns the signed and dated CMN to the infusion provider.

If the patient is hospitalized or admitted to a nursing home, the current CMN is automatically discontinued. The patient will need a new CMN when he or she returns to service. When the current services are discontinued and a new service is started, a new CMN is needed. An order change of the same therapy type during a 120-day CMN limit doesn’t need a new CMN.

The major therapy types are specified by the Healthcare Common Procedure Coding System, as indicated below:

HCPCS codes

Major therapy types

S5498 to S5502

Catheter care

S5517 to S5518

Catheter restoration

S5520 to S5523

Line insertion

S9235 to S9325

Pain management

S9329 to S9331

Chemotherapy

S9336

Continuous anticoagulant infusions

S9338

Immunotherapy

S9346

Alpha 1 proteinase inhibitor

S9347

Uninterrupted, long-term controlled rate intravenous or subcutaneous

S9348

Sympathomimetic inotropic agents

S9351

Continuous anti-emetic infusions

S9355

Chelation therapy

S9357

Enzymes replacement

S9359

Anti-tumor necrosis factor

S9361

Diuretic intravenous therapy

S9363

Anti-spasmodic intravenous

S9364 to S9368

TPN

S9370

Intermittent anti-emetic injections

S9372

Intermittent anticoagulant

S9373 to S9377

Hydration therapy

S9390

Corticosteroid infusion

S9494 to S9504

Antibiotic, antiviral, antifungal therapy

S9537

Injectable hematopoietic hormone

S9642

Injectable, not otherwise classified

Failure to meet these requirements may result in an audit recovery. If you have any questions, contact your provider consultant.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2014 American Medical Association. All rights reserved.